» Articles » PMID: 12654794

Attenuated Yersinia Enterocolitica Mutant Strains Exhibit Differential Virulence in Cytokine-deficient Mice: Implications for the Development of Novel Live Carrier Vaccines

Overview
Journal Infect Immun
Date 2003 Mar 26
PMID 12654794
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Yersinia enterocolitica mutant strains, including mutants deficient in the chaperone SycH resulting in a functional deficiency in tyrosine phosphatase (YopH), Mn-cofactored superoxide dismutase (SodA), iron-repressive protein 1 (IRP-1), and Yersinia adhesin A (YadA), were demonstrated to be highly attenuated in wild-type C57BL/6 mice. TNFRp55(-/-), IL-12p40(-/-), and IL-18(-/-) mutant mice, in which the Yersinia wild-type strain causes severe systemic infections, were used to investigate whether these Yersinia mutant strains would be attenuated in immunodeficient hosts. A plasmid-cured Yersinia mutant strain was unable to colonize any of the mutant mice tested. A SycH-deficient mutant strain colonized intestinal tissues of these mice but was attenuated for systemic infection in all of the mutant mice. Both YadA- and Irp-1-deficient Yersinia mutants were still attenuated in IL-12(-/-) and IL-18(-/-) mice but were pathogenic in TNFRp55(-/-) mice. By contrast, a Yersinia sodA mutant was highly pathogenic for TNFRp55(-/-) and IL-12p40(-/-) mice while interleukin-18 (IL-18) was dispensable. This finding demonstrates that certain virulence factors enable yersiniae to compete with distinct cytokine-dependent host defense mechanisms. Moreover, while gamma interferon mRNA expression did not reflect protective host responses in cytokine-deficient mice, IL-10 expression coincided with a heavy splenic bacterial load and was associated with progressive infection courses. We can thus segregate minor (SodA), intermediate (YadA and IRP-1), and major (YopH) virulence factors of Y. enterocolitica. Finally, we demonstrate that, even in immunocompromised hosts, Yersinia sycH and, with some restrictions, irp-1 mutants may be suitable for use as live carrier vaccines.

Citing Articles

Nitric oxide-producing monocyte-myeloid suppressor cells expand and accumulate in the spleen and mesenteric lymph nodes of -infected mice.

Leporati M, Di Genaro M, Elicabe R Front Cell Infect Microbiol. 2024; 14:1440514.

PMID: 39529636 PMC: 11551114. DOI: 10.3389/fcimb.2024.1440514.


A Computational Model of Bacterial Population Dynamics in Gastrointestinal Infections in Mice.

Geissert J, Bohn E, Mostolizadeh R, Drager A, Autenrieth I, Beier S Biology (Basel). 2022; 11(2).

PMID: 35205164 PMC: 8869254. DOI: 10.3390/biology11020297.


Yersinia pseudotuberculosis YopH targets SKAP2-dependent and independent signaling pathways to block neutrophil antimicrobial mechanisms during infection.

Shaban L, Nguyen G, Mecsas-Faxon B, Swanson K, Tan S, Mecsas J PLoS Pathog. 2020; 16(5):e1008576.

PMID: 32392230 PMC: 7241846. DOI: 10.1371/journal.ppat.1008576.


Treatment of reactive arthritis with biological agents: a review.

Zeng H, Luo B, Zhang Y, Xie Z, Ye Z Biosci Rep. 2020; 40(2).

PMID: 32039436 PMC: 7033307. DOI: 10.1042/BSR20191927.


IL-12/23p40 overproduction by dendritic cells leads to an increased Th1 and Th17 polarization in a model of Yersinia enterocolitica-induced reactive arthritis in TNFRp55-/- mice.

Mayordomo A, Silva J, Gorlino C, Arias J, Beron W, Di Genaro M PLoS One. 2018; 13(3):e0193573.

PMID: 29494692 PMC: 5832265. DOI: 10.1371/journal.pone.0193573.


References
1.
Lahesmaa-Rantala R, Granfors K, Kekomaki R, Toivanen A . Circulating yersinia specific immune complexes after acute yersiniosis: a follow up study of patients with and without reactive arthritis. Ann Rheum Dis. 1987; 46(2):121-6. PMC: 1002077. DOI: 10.1136/ard.46.2.121. View

2.
Ruckdeschel K, Mannel O, Richter K, Jacobi C, Trulzsch K, Rouot B . Yersinia outer protein P of Yersinia enterocolitica simultaneously blocks the nuclear factor-kappa B pathway and exploits lipopolysaccharide signaling to trigger apoptosis in macrophages. J Immunol. 2001; 166(3):1823-31. DOI: 10.4049/jimmunol.166.3.1823. View

3.
Calin A, Goulding N, Brewerton D . Reactive arthropathy following Salmonella vaccination. Arthritis Rheum. 1987; 30(10):1197. DOI: 10.1002/art.1780301021. View

4.
Hanski C, Kutschka U, Schmoranzer H, Naumann M, Stallmach A, Hahn H . Immunohistochemical and electron microscopic study of interaction of Yersinia enterocolitica serotype O8 with intestinal mucosa during experimental enteritis. Infect Immun. 1989; 57(3):673-8. PMC: 313160. DOI: 10.1128/iai.57.3.673-678.1989. View

5.
Cover T, Aber R . Yersinia enterocolitica. N Engl J Med. 1989; 321(1):16-24. DOI: 10.1056/NEJM198907063210104. View